Evaluation of TG-HDL Ratio Instead of HOMA Ratio as Insulin Resistance Marker in Overweight and Children with Obesity

Homeostasis model assessment for insulin resistance (HOMA-IR) is widely used as a marker of insulin resistance in adults and has also been validated in children and adolescents. Triglyceride (TG) and HDL-C on the other hand is a routine test and inexpensive compared to insulin. Previous studies repo...

Full description

Saved in:
Bibliographic Details
Published inEndocrine, metabolic & immune disorders drug targets Vol. 19; no. 5; p. 676
Main Authors Behiry, Eman G, El Nady, Nazih Mohamed, AbdEl Haie, Omima M, Mattar, May Kamel, Magdy, Amira
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2019
Subjects
Online AccessGet more information
ISSN2212-3873
DOI10.2174/1871530319666190121123535

Cover

Abstract Homeostasis model assessment for insulin resistance (HOMA-IR) is widely used as a marker of insulin resistance in adults and has also been validated in children and adolescents. Triglyceride (TG) and HDL-C on the other hand is a routine test and inexpensive compared to insulin. Previous studies reported conflicting findings on the usefulness of the triglyceride to HDL-C ratio (TG:HDL-C ratio) as predictor or marker of IR. The aim of this work was to investigate the usefulness of Triglyceride to HDL-C ratio (TG/HDL-C) as an Insulin Resistance (IR) marker in overweight and children with obesity. This study was a comparative cross sectional study which was conducted on ninety overweight and children with obesity attending National Nutrition Institute "Pediatric obesity clinic. They were classified into 2 groups as follows: group (1) included overweight and children with obesity with insulin resistance, group (2) included overweight and children with obesity with non-insulin resistance. All the subjects were subjected to history, clinical examination and laboratory investigations including total lipid profile, fasting glucose, insulin and TG:HDL-C ratio instead of HOMA ratio. Prevalence of IR among the studied sample was 42 (46.7%). Mean value of TG/ HDL-C ratio was greater among the insulin resistance group than non insulin resistance group (p value= < 0.001)value). TG/HDL ratio ≥1.36 had 85.7% sensitivity, 66.7% specificity. There was statistically significant positive correlation between TG/HDL ratio and HOMA-IR. TG:HDL ratio ≥1.36 is a significant early and sensitive predictor of insulin resistance in children instead of HOMA-IR.
AbstractList Homeostasis model assessment for insulin resistance (HOMA-IR) is widely used as a marker of insulin resistance in adults and has also been validated in children and adolescents. Triglyceride (TG) and HDL-C on the other hand is a routine test and inexpensive compared to insulin. Previous studies reported conflicting findings on the usefulness of the triglyceride to HDL-C ratio (TG:HDL-C ratio) as predictor or marker of IR. The aim of this work was to investigate the usefulness of Triglyceride to HDL-C ratio (TG/HDL-C) as an Insulin Resistance (IR) marker in overweight and children with obesity. This study was a comparative cross sectional study which was conducted on ninety overweight and children with obesity attending National Nutrition Institute "Pediatric obesity clinic. They were classified into 2 groups as follows: group (1) included overweight and children with obesity with insulin resistance, group (2) included overweight and children with obesity with non-insulin resistance. All the subjects were subjected to history, clinical examination and laboratory investigations including total lipid profile, fasting glucose, insulin and TG:HDL-C ratio instead of HOMA ratio. Prevalence of IR among the studied sample was 42 (46.7%). Mean value of TG/ HDL-C ratio was greater among the insulin resistance group than non insulin resistance group (p value= < 0.001)value). TG/HDL ratio ≥1.36 had 85.7% sensitivity, 66.7% specificity. There was statistically significant positive correlation between TG/HDL ratio and HOMA-IR. TG:HDL ratio ≥1.36 is a significant early and sensitive predictor of insulin resistance in children instead of HOMA-IR.
Author Magdy, Amira
Mattar, May Kamel
El Nady, Nazih Mohamed
AbdEl Haie, Omima M
Behiry, Eman G
Author_xml – sequence: 1
  givenname: Eman G
  surname: Behiry
  fullname: Behiry, Eman G
  organization: Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Benha, Egypt
– sequence: 2
  givenname: Nazih Mohamed
  surname: El Nady
  fullname: El Nady, Nazih Mohamed
  organization: Department of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt
– sequence: 3
  givenname: Omima M
  surname: AbdEl Haie
  fullname: AbdEl Haie, Omima M
  organization: Department of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt
– sequence: 4
  givenname: May Kamel
  surname: Mattar
  fullname: Mattar, May Kamel
  organization: Department of Childhood Studies, National Nutrition Institute, Cairo University, Cairo, Egypt
– sequence: 5
  givenname: Amira
  surname: Magdy
  fullname: Magdy, Amira
  organization: Department of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30663576$$D View this record in MEDLINE/PubMed
BookMark eNo1z91qAjEQBeBQWqq1vkJJH2DbJJOfzaVYq4KyIPZakt3ZGrpG2R_Ft69SezXwHc6BeSL3cR-RkFfO3gQ38p2nhitgwK3WmlvGBecCFKg70heCiwRSAz0ybJrgmQJILYB5JD1gWoMyuk-6ydFVnWvDPtJ9SdfTZPaxoKsr0HlsWnTF1WfZcnRT11yDrgqRrrAJTetijnTp6h-s6QWzI9YnDN_blrpY0PE2VEWNkZ5Cu6WZv1Ta8zN5KF3V4PB2B-Trc7Iez5JFNp2PR4vES8PahDMw1uYGcpsqKFyBvBAoEZSzHLzUmObOpsbbUnolvXSmFEyjkI5xb3IxIC9_u4fO77DYHOqwc_V58_-_-AUJq18n
CitedBy_id crossref_primary_10_1080_17425247_2024_2361117
crossref_primary_10_3390_nu12113582
crossref_primary_10_1002_brb3_3453
crossref_primary_10_1016_j_atherosclerosis_2022_01_001
crossref_primary_10_2174_0118715303245154231023104618
crossref_primary_10_4103_jehp_jehp_972_23
crossref_primary_10_7759_cureus_58612
crossref_primary_10_1186_s12876_024_03127_9
crossref_primary_10_3390_molecules26113262
crossref_primary_10_1080_2574254X_2021_1903297
crossref_primary_10_1155_2022_5457087
crossref_primary_10_1080_08039488_2021_1968489
crossref_primary_10_1371_journal_pone_0238600
crossref_primary_10_3389_fendo_2024_1384059
crossref_primary_10_31744_einstein_journal_2023AO0251
crossref_primary_10_17352_ojpch_000050
crossref_primary_10_3389_fgene_2024_1436947
crossref_primary_10_3390_biomedicines12071493
crossref_primary_10_1002_lipd_12429
crossref_primary_10_7759_cureus_41881
crossref_primary_10_1155_2021_6633700
crossref_primary_10_3390_diagnostics13162656
crossref_primary_10_1089_met_2020_0046
crossref_primary_10_24293_ijcpml_v30i1_2198
crossref_primary_10_1016_j_semerg_2021_05_007
crossref_primary_10_1002_edm2_329
crossref_primary_10_1007_s42000_021_00272_8
crossref_primary_10_1007_s12098_021_03806_5
crossref_primary_10_1016_j_heliyon_2021_e06139
crossref_primary_10_3390_nu15092105
crossref_primary_10_1186_s12950_020_00264_2
crossref_primary_10_3390_medicina55090579
crossref_primary_10_3390_metabo13010100
crossref_primary_10_3389_fendo_2022_947157
crossref_primary_10_1155_2022_1673335
crossref_primary_10_1155_2021_9949579
crossref_primary_10_3390_diagnostics13213356
crossref_primary_10_3389_fendo_2021_633856
crossref_primary_10_3389_fendo_2024_1477419
crossref_primary_10_1186_s43162_023_00269_2
crossref_primary_10_28982_josam_863978
crossref_primary_10_3390_ph15040492
crossref_primary_10_1007_s13410_024_01417_2
crossref_primary_10_1038_s41588_023_01625_2
crossref_primary_10_1089_met_2022_0086
crossref_primary_10_1186_s12876_023_03007_8
ContentType Journal Article
Copyright Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Copyright_xml – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2174/1871530319666190121123535
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2212-3873
ExternalDocumentID 30663576
Genre Journal Article
Comparative Study
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-b470t-103799c73c9853dade1d2e4e35a913b46e8ca987b9f4b54b4a7f206e24a01b7c2
IngestDate Thu Jan 02 22:59:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords TG/HDL
HOMA
insulin resistance
overweight
C ratio
obese
Language English
License Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b470t-103799c73c9853dade1d2e4e35a913b46e8ca987b9f4b54b4a7f206e24a01b7c2
PMID 30663576
ParticipantIDs pubmed_primary_30663576
PublicationCentury 2000
PublicationDate 2019-01-01
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
PublicationTitle Endocrine, metabolic & immune disorders drug targets
PublicationTitleAlternate Endocr Metab Immune Disord Drug Targets
PublicationYear 2019
SSID ssib053389337
Score 2.3769832
Snippet Homeostasis model assessment for insulin resistance (HOMA-IR) is widely used as a marker of insulin resistance in adults and has also been validated in...
SourceID pubmed
SourceType Index Database
StartPage 676
SubjectTerms Adolescent
Biomarkers - analysis
Biomarkers - blood
Case-Control Studies
Child
Cholesterol, HDL - analysis
Cholesterol, HDL - blood
Cross-Sectional Studies
Female
Humans
Insulin Resistance
Male
Metabolic Syndrome - blood
Metabolic Syndrome - diagnosis
Overweight - blood
Overweight - complications
Overweight - diagnosis
Pediatric Obesity - blood
Pediatric Obesity - complications
Pediatric Obesity - diagnosis
Triglycerides - analysis
Triglycerides - blood
Title Evaluation of TG-HDL Ratio Instead of HOMA Ratio as Insulin Resistance Marker in Overweight and Children with Obesity
URI https://www.ncbi.nlm.nih.gov/pubmed/30663576
Volume 19
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6cFkIupaWv9MUWehNq7dXK8h5D6ta0dQzBgdzC7mpUCyI7xPah-Zv9Q53ZXT1iEmh7EWbWHoTm82jew9gHBVoADCAWoxzQQbF5rKEwsSqMltpkqbGU0Z2eDCdn8tt5et7r_e5ULW035qO9ubOv5H-kijSUK3XJ_oNkG6ZIwM8oX7yihPH6VzIeN6O6yeabf40nn39Ep0RwRQAoPhenn02PAlWv6cAVn5_CmkxH97-mEh0qS49mrkya_HWXVDjudnpHYYfArVj-Ml_Z69JHRSvYIKJoaDbBqaTGE6AEkJvuuY7y6-3PyBeet6F5WJQ-jz-mXEKz52t8iWq_Vv835QJVz0JXoQ_LJaty_MpE--TKrCor3YZ1aYW5Lxuf6l_Rd_zdZTe2Qe1UTWwDnA4UgmYqjvy2k0Zhqw4w0472HfpVMrtvBfK6KECBvmGaUNcWumxkB6HvK5LUT0vpoOWqcnBJnDF2m-PdpzsDu-ujPbaXZfSuOGkDSGhco4GYZPvsfbixT_fe1gHbr1nt-DzO9pk_Zo-C08KPPAKfsB4sn7Jtiz6-KrhHH3c44wF9RCf0Bape84A-3qKPe_RxJLbo44g-XqOPE_p4QN8zdvZlPD-exGGJR2xk1t_E1IeqlM0Sq9AyzHUOg1yAhCTVapAYOYSR1WqUGVVIk0ojdVaI_hCE1P2Byax4zh4sV0t4ybhC81b3kY81hZQGDatBXiBnoY2yUtpD9sI_pYsrP6nlon5-r-49ec0OWuC9YQ8LVA3wFu3MjXnnJPcHrnN7Pg
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+TG-HDL+Ratio+Instead+of+HOMA+Ratio+as+Insulin+Resistance+Marker+in+Overweight+and+Children+with+Obesity&rft.jtitle=Endocrine%2C+metabolic+%26+immune+disorders+drug+targets&rft.au=Behiry%2C+Eman+G&rft.au=El+Nady%2C+Nazih+Mohamed&rft.au=AbdEl+Haie%2C+Omima+M&rft.au=Mattar%2C+May+Kamel&rft.date=2019-01-01&rft.eissn=2212-3873&rft.volume=19&rft.issue=5&rft.spage=676&rft_id=info:doi/10.2174%2F1871530319666190121123535&rft_id=info%3Apmid%2F30663576&rft_id=info%3Apmid%2F30663576&rft.externalDocID=30663576